Blog
Women in Leadership in the Life Sciences – Gretchen Bowker will speak during IHIF Life Sciences Lunch
Gretchen Bowker, CEO of Pearl IRB, will share insights during an Indiana Health Industry Forum (IHIF) lunch event on Tuesday, September 18, 2018. The lunch event, "Women in Leadership in the Life Sciences", is part of IHIF's recurring Life Sciences Lunch...
Informed consent form posting requirement to change under new Final Rule
The Final Rule to update the current regulations at 45 CFR 46, Subpart A - "Federal Policy for the Protection of Human Subjects" (the Common Rule) was published by the U.S. Department of Health and Human Services (DHHS) on 19 January 2017 in the Federal...
Pearl IRB hires experienced biopharmaceutical, medical device leader as Director of Business Development
Pearl IRB announces the hiring of Cara Frosch, MBA, PA as Director of Business Development. Frosch brings over 35 years of diversified biopharmaceutical and medical device experience in human and animal health to Pearl IRB and Pearl Pathways. After a short...
FDA draft guidance aims to expedite first-in-human clinical trials for oncology drugs and biologics
A new draft guidance issued by the U.S. Food and Drug Administration (FDA) provides advice to sponsors regarding the design and conduct of first-in-human (FIH) clinical trials for cancer drugs and biologics. The draft guidance, issued in August 2018,...
Clinical labs experience increased demand for data management solutions
In clinical labs, a persistent need for lab information management software exists. However, up until recently most companies would purchase many different types of software systems and then customize it to meet the laboratory’s needs. In order to...